A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

ClinicalTrials.gov ID: NCT05135975

Public ClinicalTrials.gov record NCT05135975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 30, 2026, 11:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2 Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Study identification

NCT ID: NCT05135975
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Nationwide Children's Hospital; Other
Enrollment: 86 participants

Conditions and interventions

Conditions

Interventions

Cabozantinib Drug

Drug

Eligibility (public fields only)

Age range: 18 Months to 40 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 19, 2022
Primary completion: Jun 30, 2026
Completion: Nov 30, 2029
Last update posted: Aug 11, 2025

2022 – 2029

United States locations

U.S. sites: 6
U.S. states: 6
U.S. cities: 6

Facility	City	State	ZIP	Site status
Children's Hospital of Alabama/UAB	Birmingham	Alabama	35233	Recruiting
Children's Hospital of Colorado	Aurora	Colorado	80045	Recruiting
Children's National Medical Center	Washington D.C.	District of Columbia	20010	Recruiting
Children's Hospital at Montefiore	The Bronx	New York	10467	Recruiting
Nationwide Children's Hospital	Columbus	Ohio	43205	Recruiting
Primary Children's Hospital	Salt Lake City	Utah	84113	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05135975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 11, 2025 · Synced Apr 30, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05135975 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →